Autolus Therapeutics (AUTL) Misses Q1 EPS by 2c, Misses on Revenue; Offers FY26 Revenue Guidance

Go back to Autolus Therapeutics (AUTL) Misses Q1 EPS by 2c, Misses on Revenue; Offers FY26 Revenue Guidance
(NASDAQ: AUTL) Delayed: 1.51 -0.02 (1.31%)
Previous Close $1.53    52 Week High
Open $1.55    52 Week Low
Day High $1.59    P/E N/A 
Day Low $1.51    EPS
Volume 844,822